A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress
Mark L. Laudenslager(University of Colorado Anschutz Medical Campus), Susan K. Mikulich‐Gilbertson(University of Colorado Anschutz Medical Campus), Sharon Philips(University of Colorado Anschutz Medical Campus), Jessica Marie Spradley(Colorado Blood Cancer Institute), Crystal Natvig(University of Colorado Anschutz Medical Campus), Teresa L. Simoneau(University of Colorado Anschutz Medical Campus), Peter A. McSweeney(Mesoblast (United States)), Pedro Pablo Ferro Benítez(University of Colorado Anschutz Medical Campus), Kristin Kilbourn(University of Colorado Denver)
Cited by 92
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k